Year 2019, football, rugby, netball and skiing had most occurring ACL injuries, listed by United Kingdom National Ligament Report (NLR). The standard procedure treatment of complete laceration of the ACL, is performed by tissue autograft implantation designed from a patellar tendon, for replacement of damaged tissue using orthopaedic surgery. The aim of this thesis is to design and fabricate an ACL graft, attempting to mimic the natural ACL, for the purpose of tissue reconstruction. The desired graft analogues exhibited properties imitating native connective tissue, reducing pain through drug delivery with great biocompatibility and enhance suture mechanical strength. Various biomaterials were implemented into this study, utilising strategies; polymer solution fabrication, electrospinning, hydrogel synthesis, mechanical braiding and graft assembly to fabricate an ACL graft. The polymeric material poly (E- caprolactone) (PCL) was researched, utilising its ability to fabricate scaffolds. Results showed, three analogue ACL grafts (Braided PCL-BP, Braided PCL + Hydrogel-BPH & Braided PCL + Sutures-BPS) created utilising the properties of braiding, hydrogels and sutures, ultimately improving the versatility of electrospinning for tissue engineering and reconstruction. Graft analogues were tested and compared against patellar tendons producing similar tensile properties. Poly vinyl alcohol (PVA) hydrogels successfully held ibuprofen, revealing drug delivery characteristics, polyester threads improved mechanical properties of electrospun grafts and dry degradation showed that PCL did not lose significant mass over two months. Conclusion, tensile strength of patella tendon was 395x, 790x & 56x of analogue grafts (BP, BPH & BPS) respectively, having potential for improvement of tensile parameters for ligament reconstruction.

No description available.

Avec plus de 2 millions d’interventions chirurgicales par an dans le monde, les actes de chirurgie osseuse sont les plus fréquents, ce qui pousse les entreprises du secteur des biomatériaux pour la régénération osseuse à investir massivement pour sans cesse améliorer leurs produits. Cette thèse est issue d’un contrat CIFRE effectué avec l’entreprise Kasios afin de l’aider dans le développement de céramiques et polymères poreux principalement pour des applications en chirurgie maxillo-faciale. Les travaux réalisés s’articulent autour du développement de biomatériaux biphasiques à base de phosphate tricalcique béta (β-TCP). En premier lieu, des microfibres de polycaprolactone (PCL) incorporant des particules élémentaires de β-TCP ont été fabriquées par électrospinning. Les principales applications des fibres concernent la régénération osseuse guidée pour la préservation alvéolaire ou les opérations de relevés de sinus. L’électrospinning des fibres a utilisé des solvants ne présentant pas de toxicité aiguë. Les fibres ont formé des membranes manipulables qui peuvent être facilement découpées et suturées même en environnement humide. Les études in vitro n’ont révélé aucune cytotoxicité et les membranes ont permis la prolifération de cellules ostéoblastiques. La seconde étude a permis la fabrication d’éponges de gélatine et d’acide hyaluronique saturées ou recouvertes en surface de granules de β-TCP pour le comblement alvéolaire. Les éponges étaient facilement façonnables pour correspondre à l’alvéole du patient. Le chirurgien pourrait alors bénéficier de la nature biphasique du dispositif médical afin de faciliter l’implantation et éviter la manipulation séparée des éponges et des granules. L’utilisation des éponges permettrait par ailleurs d’assurer un positionnement idéal des granules pour la cicatrisation alvéolaire. La troisième étude, plus fondamentale, porte sur l’interaction des cellules osseuses avec le β-TCP et sa résorption. Des études de biomécanique et de biodégradation ainsi que de biodissolution ont également été réalisées sur des biomatériaux produits par l’entreprise. / With more than 2 million surgeries per year, bone tissue is one of the most concerned tissues and biomaterial companies have developed massive investments to continually improve bone regeneration.This thesis was conducted during a CIFRE contract (a tripartite contract linking a student, a university and acompany) and was done in association with the company Kasios for the development of new porous polymers and ceramics. This thesis was specifically centered in the development of biphasic biomaterials based upon beta tricalcium phosphate (β-TCP). First, polycaprolacton (PCL) microfibers incorporating β-TCP elementary particles were produced using electrospinning. These fibers were developed to provide membranes for guided bone regeneration usable in alveolar preservation and sinus lifting. Electrospinning of the fibers did not require any high toxicity solvent. Our fibers formed membranes that could easily be handled, cut and sutured in dry and wet environment. In vitrocytotoxicity studies confirmed the non-toxic nature of the material and showed the ability of the membranes to encourage survival and proliferation of osteoblastic cells. Secondly, freeze-dried gelatin and hyaluronicacid sponges saturated or embedded with β-TCP granules were developed for alveolar filling. Theses ponges could easily be shaped to fit the patient’s dental socket. The biphasic nature of the sponges could make the implantation easier and faster by avoiding surgeons to handle separately the granules and the sponges. This medical device could also insure a correct and optimal positioning of the granules for the patient healing. Lastly, a fundamental study was conducted on resorption of β-TCP and the interaction between bone cells and the biomaterial. Biomechanical and biodegradation/biodissolution studies were also done on different types of biomaterials produced by the company.

L’objectif de ces travaux de recherche était de synthétiser de mousses polyuréthane (PUF) bio-basées à partir d’oligomères hydroxytéléchéliques issus du caoutchouc naturel (HTNR) ou à partir de poudrettes de pneus usagés (HTWT) et du diol de la polycaprolactone (PCL) comme segments soft. Les paramètres étudiés ont été le type de polyol et le rapport molaire entre HTNR/PCL et HTWT/PCL. La masse molaire de HTNR, HTWT et PCL étaient respectivement 1,800, 1400 et 2000 g/mol. L’effet du rapport molaire HTNR/PCL et HTWT/PCL (1/0, 1/0/5/, 1/1, et 0.5/1) sur la vitesse de formation des mousses et sur les propriétés chimiques et physiques a été étudié. Les structures chimiques de HTNR, HTWT et PUF ont été confirmées par FTIR et 1H-RMN. Le diol de la PCL était le plus réactif donc augmentant le contenu de PCL-diol la vitesse de formation des mousses a augmenté. La densité des mousses a changé légèrement avec le rapport molaire cependant la résistance à la traction reste dans la même gamme. Le diamètre moyen des cellules a augmenté en fonction du contenu de PCL-diol et la tendance inverse a été observée pour l’allongement à la rupture et la résistance à la compression. L’observation au microscope électronique à balayage (MEB) a montré que les mousses basées sur les HTNR étaient alvéolées et fermées. La biodégradabilité a été évaluée selon le test de Sturm. Polyéthylène à baisse densité et benzoate de sodium ont été utilisés respectivement comme témoins négatif et positif. Les mousses ont montré une période d’induction de 33 jours dans lequel le pourcentage de dégradation était ~ 7-10%. La biodégradation de PUF contenant seulement HTNR a été 8.4% après 28 jours et 31.89% après 60 jours ; les PUF contenants 1/0.5 HTNR/PCL ont montré un pourcentage supérieure : 11.31% après 28 jours et 45.6% après 60 jours. Le rapport molaire HTWT/PCL a influencé beaucoup la vitesse de formation des mousses et leur morphologie. Cellules fermées de forme polyédrique ont été observé par microscopie électronique à balayage. Les résultats de l’analyse thermogravimétrique ont montré que l’addition du diol de la PCL a augmenté la température de dégradation. Il a été observé qu’une basse vitesse de réaction génère des mousses à haute densité, petit diamètre de cellule et haute distribution des diamètres. La biodégradation des PUF contenant seulement HTWT a été 31.2% après 28 jours et 51.3% après 60 jours, tandis que les PUF contenant 1/0.5 HTWT/PCL ont montré une dégradation plus élevée : 39.1% après 28 jours et 64.3% après 60 jours. La vitesse de formation des mousses basées sur les HTWT était supérieure à celle des mousses basées sur les HTNR. Toutes les mousses basées sur les HTWT ont une densité supérieure et une taille de cellule inférieure à celles basées sur HTNR. La structure des cellules des mousses basées sur les HTNR ou HTWT était différente cependant toutes les mousses ont montré des cellules quasi complètement fermées. Les mousses basées sur les HTWT ont montré des propriétés thermiques et de biodégradation meilleures par rapport aux mousses basées sur les HTNR. / The aim of this research was to prepare a bio-based polyurethane foam (PUF) containing hydroxyl telechelic oligomers from natural rubber (HTNR) and waste tire crumbs (HTWT) and polycaprolactone diol (PCL) as soft segments. The studied parameters included type of polyols and molar ratio between HTNR/PCL and HTWT/PCL. The molecular weight of HTNR and HTWT derived from 1H-NMR spectra were 1,800 and 1,400 g/mol, respectively. The molecular weight of PCL diol was 2000 g/mol. The effect of HTNR/PCL and HTWT/PCL molar ratio (1/0, 1/0.5, 1/1 and 0.5/1) on the foam formation rate and physical and chemical properties of the resulting PUF was investigated. The chemical structure of HTNR, HTWT and PUF were confirmed by FTIR and 1H-NMR. PCL diol provided faster reaction, thus higher PCL diol content showed higher foam formation rate. The foam density slightly changed with the molar ratio whereas the specific tensile strength of all samples was in the same range. The average diameter of cell increased with increasing contents of PCL diol. The addition of PCL diol resulted in reduced elongation at break and compressive strength. The cellular structure observed by SEM micrographs of HTNR based foams showed an almost closed cell. The biodegradability was assessed according to a modified Sturm test. Low density polyethylene and sodium benzoate were used as a negative and positive control sample, respectively. PUF samples showed an induction time of 33 days in which the percentage of biodegradation was  7-11%. The biodegradation of PUF containing only HTNR was 8.4% and 31.89% at 28 days and 60 days of testing respectively whereas the PUF containing 1/0.5 HTNR/PCL (by mole) showed a higher biodegradation: 11.31% and 45.6% at 28 days and 60 days of testing respectively. The molar ratio of HTWT/PCL strongly affected the kinetic rate of foam formation and foam morphology. According to SEM micrographs, polyhedral closed cells were observed. The addition of the PCL diol increased the thermal degradation temperature of the PUF based on TGA results. A low kinetic rate provided PUF with a high density, small cell size and a broad cell size distribution. The biodegradation of PUF containing only HTWT was 31.2% and 51.3% at 28 days and 60 days of testing respectively whereas the PUF containing 1/0.5 HTWT/PCL diols (by mole) showed a higher biodegradation: 39.1% and 64.3% at 28 days and 60 days of testing respectively. The foam formation rate of HTWT based PUF was higher than the one of HTNR based PUF. All HTWT based PUF have a higher density than HTNR based PUF. The HTWT based PUF had an inferior cell size in comparison to HTNR based PUF. The cellular structure of HTNR based and HTWT based PUF were different, but all PUFs showed almost closed cells. The HTWT based PUF had a higher thermal degradation temperature and biodegradation properties than foams from HTNR. / วัตถุประสงค์ของงานวิจัยนี้ เพื่อทำการเตรียมโฟมพอลิยูรีเทนชีวภาพ (PUF) จากยางธรรมชาติดัดแปรที่มีหมู่ปลายไฮดรอกซิล (HTNR) ยางคลัมบ์ดัดแปรที่มีหมู่ปลาย ไฮดรอกซิล (HTWT) และพอลิคาโปรแลคโทน (PCL) ศึกษาผลของชนิดพอลิออล และสัดส่วนโดยโมลระหว่าง HTNR/PCL และ HTWT/PCL ที่สัดส่วน 1/0, 1/0.5, 1/1 และ 0.5/1 โดยโมล นํ้าหนักโมเลกุลของ HTNR, HTWT และ PCL ที่ใช้สำหรับงานวิจัยนี้ คำนวณจาก 1H-NMR คือ 1,800, 1,400 และ 2,000 g/mol ตามลำดับ ลักษณะโครงสร้างทางเคมีของ HTNR, HTWT และPUF สามารถวิเคราะห์และยืนยันด้วยเทคนิค FTIR และ 1H-NMR รวมถึงทำการวัดอัตราการก่อโฟม (Foam formation rate) ทดสอบสมบัติทางกายภาพ ทางเคมี และสมบัติการย่อยสลายทางชีวภาพ พบว่าในกรณีของโฟมพอลิยูรีเทนจาก HTNR/PCL เมื่อใช้ PCL ในปริมาณที่มากขึ้นจะส่งผลให้อัตราการก่อโฟมเร็วขึ้น และขนาดของเซลโฟมมีขนาดใหญ่ขึ้นด้วย ในขณะที่ค่าความหนาแน่น และความต้านทานต่อแรงดึงจำเพาะมีการเปลี่ยนแปลงเล็กน้อย การเติม PCL ในส่วนผสมของโฟมยังส่งผลให้ความสามารถในการยืด ณ จุดขาด และความทนทานต่อการกดมีค่าลดลง การคืนตัวหลังการกดของโฟม PUF2 (สัดส่วนระหว่าง HTNR/PCL = 1/0.5) จะให้ค่าตํ่าที่สุดคือ 40% ลักษณะของโฟมที่ได้จากการทดลองนี้โดยส่วนใหญ่จะเป็นแบบเซลปิด ความสามารถในการย่อยสลายทางชีวภาพของโฟม ทดสอบโดยใช้วิธี Sturm Test มี LDPE เป็นตัวเปรียบเทียบเชิงลบ และใช้ Sodium benzoate เป็นตัวเปรียบเทียบเชิงบวก พบว่าโฟมเริ่มมีการย่อยสายเกิดขึ้นอย่างเห็นได้ชัดที่เวลา 33 วัน มีเปอร์เซ็นต์การย่อยสลายในช่วง 7-11 เปอร์เซ็นต์ เปอร์เซ็นต์การย่อยสลายของโฟมจาก HTNR (PUF1) อยู่ที่ระดับ 8.4 และ 31.89 เปอร์เซ็นต์ และเปอร์เซ็นต์การย่อยสลายของโฟมจาก HTNR/PCL (1/0.5) อยู่ที่ระดับ 11.31 และ 45.6 เปอร์เซ็นต์ ที่เวลาในการทดสอบ 28 และ 60 วัน ตามลำดับ กรณีของโฟมพอลิยูรีเทนจาก HTWT/PCL เมื่อใช้ PCL ในปริมาณที่มากขึ้นจะส่งผลให้ค่าความหนาแน่นสูงขึ้น ขนาดของเซลโฟมลดลงมีการกระจายของเซลในวงกว้างไม่สมํ่าเสมอ เปอร์เซ็นต์การย่อยสลายทางชีวภาพของโฟมจาก HTWT (PUF5) อยู่ที่ระดับ 31.2 และ 51.3 เปอร์เซ็นต์ และเปอร์เซ็นต์การย่อยสลายของโฟมจาก HTWT/PCL (1/0.5) อยู่ที่ระดับ 39.1 และ 64.3 เปอร์เซ็นต์ ที่เวลาในการทดสอบ 28 และ 60 วัน ตามลำดับ เมื่อทำการเปรียบเทียบโฟมที่ได้จากการเตรียมโดยใช้พอลิออลหลักเป็น HTNR และ HTWT พบว่าโฟมจากพอลิออลหลัก HTWT ให้อัตราการก่อตัวของโฟมเร็วกว่า ขนาดของเซลโฟมเล็กกว่า ความหนาแน่น ความต้านทานต่อความร้อน และเปอร์เซ็นต์การย่อยสลายทางชีวภาพสูงกว่า เมื่อเทียบกับโฟมจากพอลิออลหลัก HTNR

The master's thesis focuses on preparation of blown films from polylactid acid (PLA) which was blended with selected polyesteres – poly(butylene adipate-co-terephtalate) (PBAT), polycaprolactone (PCL) and polybutylene succinate (PBS) – and thermoplastic starch (TPS) in amount of 30% in order to soften PLA films. The influence of the aditives on static and mechanical tensile properties, on structure, morphology and thermal properties of the films was determined and the obtained parameters were compared to properties of films prepared from neat PLA and high density polyethylene (HDPE). The results showed that the additives increased crystalinity of PLA and thus significantly influenced the properties of the films. In contrast to the film from neat PLA, softening in terms of lowering glass transition temperature occured only by adding PBS and TPS, in terms of increasing ductility only by adding PBAT. All PLA films showed nearly constant elastic modulus up to the beginning of glass transition enabling their potential application till 50 °C. Preparation of the film with TPS was problematic and the film showed the worst mechanical properties. Preparation of other films was without any problems. The most promising additive from the tested ones was PBAT which showed comparable mechanical properties as the film from HDPE.

The aim of this pilot study was to evaluate the bioactive, surface-coated polycaprolactone-co-lactide scaffolds as bone implants in a tibia critical size defect model. Polycaprolactone-co-lactide scaffolds were coated with collagen type I and chondroitin sulfate and 30 piled up polycaprolactone-co-lactide scaffolds were implanted into a 3 cm sheep tibia critical size defect for 3 or 12 months (n¼5 each). Bone healing was estimated by quantification of bone volume in the defects on computer tomography and microcomputer tomography scans, plain radiographs, biomechanical testing as well as by histological evaluations. New bone formation occurred at the proximal and distal ends of the tibia in both groups. The current pilot study revealed a mean new bone formation of 63% and 172% after 3 and 12 months, respectively. The bioactive, surface coated, highly porous three-dimensional polycaprolactone-co-lactide scaffold stack itself acted as a guide rail for new bone formation along and into the implant. These preliminary data are encouraging for future experiments with a larger group of animals.

PhD (Department of Biotechnology, Faculty of Applied and Computer Sciences), Vaal University of Technology. / Tulbaghia violacea Harv. has found extensive uses in traditional medicine for the treatment of numerous ailments among which are tuberculosis, oesophageal cancer, diabetes and cardiovascular diseases. Current reports show that cardiovascular diseases are now the primary cause of mortality worldwide. Thus, the potential of T. violacea plant extracts against cardiovascular diseases should be explored. The objectives of this study were, (i) to conduct qualitative and quantitative preliminary phytochemical screening of T. violacea aqueous leaf extracts, (ii) to conduct Gas chromatography–mass spectrometry (GC-MS) analysis for screening of compounds present in the plant extract, (iii) to evaluate the antioxidant activity of the T. violacea crude extracts using the DPPH:1.1-diphenyl-2-picrylhydrazyl and ABTS: 2,2-azino-bis 3-ethylebenzthiazoline-6-sulfonic acid assays, (iv) to evaluate the antimicrobial activity of the T. violacea crude extracts using disk diffusion and Minimum inhibitory concentration/Minimum bactericidal concentration (MIC/MBC), (v) to evaluate the antithrombogenic properties of T. violacea crude extracts on polystyrene, (vi) to fabricate polycaprolactone (PCL) and PCL-T. violacea incorporated scaffolds, (vii) to evaluate the antithrombogenic properties of T. violacea crude extracts on the fabricated PCL and PCL-T. violacea fabricated scaffolds and, (viii) to evaluate the growth and differentiation of adipose derived stem cells (ADSCs) on the fabricated scaffolds. The qualitative and quantitative phytochemical screening was conducted using standard procedures. Folin-Ciocalteu method was used to evaluate both total phenolic content (TPC) and total tannin content (TTC), the Aluminium chloride method was used for total flavonoid content (TFC) and GC-MS was used to screen for compounds present in the plant extract. The antioxidant activity was evaluated using DPPH and ABTS and the antimicrobial activity was evaluated using disc diffusion and MIC/MBC assays. The antithrombogenic properties of the T. violacea aqueous leaf extracts was then evaluated using platelet activation and whole blood clotting kinetics on polystyrene discs which have been reported to induce platelet activation. The experiment was performed in the absence and presence of 100 and 1000 μg/ml T. violacea plant extracts for both the platelet activation study which used blood plasma and the whole blood clotting kinetics assay which used fresh whole blood. Platelet adhesion was evaluated using fluorescence microscopy and a scanning electron microscope (SEM) was used to evaluate their morphology. Three scaffolds designated as PCL, 10% Tvio and 15% Tvio were fabricated which consisted of a 10% PCL powder and 10% as well as 15% T. violacea aqueous plant extract with respect to the PCL powder weight. The scaffolds were then characterized using Fourier-transform infrared spectroscopy (FTIR) and Energy-dispersive x-ray spectroscopy (EDS). The scaffolds were then evaluated for their antithrombogenic properties in the presence and absence of 100 and 1000 μg/ml T. violacea plant extracts. Platelet adhesion was evaluated using a fluorescent microscope and the morphology was evaluated using SEM. For the cell study, adipose derived stem cells (ADSCs) were cultured on the designed scaffolds and evaluated for their toxicity, viability, adhesion, proliferation, morphology and differentiation into osteoblasts over a period of 3 weeks. Lactate dehydrogenase (LDH) assay was used for toxicity studies, alamar blue assay was used for viability, fluorescence microscopy was used to evaluate cellular adhesion and proliferation while the alkaline phosphate (ALP) assay was used to evaluate differentiation of the cells into osteoblasts. Cell morphology was evaluated using SEM. Phytochemical screening of the prepared T. violacea aqueous extract revealed the presence of terpenoids, flavonoids, cardiac glycosides, saponins, protein, phenols, tannins, carbohydrates and amino acids. This is the first study that has identified the presence of carbohydrates and amino acids in T. violacea aqueous leaf extracts. Different concentrations of 0.1, 1.0 and 10 mg/ml of plant extract were used to conduct the quantitative phytochemical screening assays. There was a concentration dependent increase in the amount of phenols, tannins and flavonoids as the concentration of the plant extracts increased. This was the first study that evaluated the total tannic content of T. violacea plant extracts. The amount of total phenols was higher than that of flavonoids and tannins at every concentration range studied followed by the total flavonoids and lastly total tannins. The GC-MS analysis showed the presence of 33 compounds among which were 2,4 – Dithiapentate - 2,2-dioxide, Cannabidiol, 2,4,5,7 –Tetrathiaoctane and 2,4,5,7 - Tetrathiaoctane 2-dioxide. The presence of sulphur compounds support the characteristic garlic-like smell as well as some of the biological activities of T. violacea plant extracts. The antioxidant activities based on DPPH (0.49 mg/ml) and ABTS (0.24 mg/ml) suggest that T. violacea can be used as potential antioxidant agents. For the antimicrobial activity using disc diffusion, the extracts exhibited appreciable antibacterial activities against Bacillus subtilis, Serratia marcescens, Staphylococcus aureus and S. epidermidis. The highest zone of inhibition was observed for S. epidermidis at 19.50 ± 0.87 mm. The MIC results revealed that the plant extract of T. violacea was moderately active against B. subtilis, S. aureus, S. epidermidis, E. coli, and S. marcescens with MIC value of 2.5 mg/ml. However, the antimicrobial effect of the extract on S. epidermidis was bactericidal when compared to the bacteriostatic effect on the other active microorganisms. The antithrombogenic results on the polystyrene discs showed a significant reduction in the number of platelets that adhered on the polystyrene surfaces treated with plasma mixed with 100 μg/ml of plant extract when compared to the untreated control and the 1000 μg/ml treatment. For the 1000 μg/ml treatment, there was a significant increase in the number of platelets that adhered to polystyrene surfaces. These results were confirmed by the fluorescence and SEM results which showed a higher platelet count for the 1000 μg/ml treatment when compared to the other groups. The whole blood clotting kinetics study showed delayed blood clotting with the 100 μg/ml treatment over a period of 60 min when compared to the untreated control and the 1000 μg/ml treatment. These results correspond with the lower platelet adhesion observation and thus confirm the anticlotting properties of T. violacea aqueous leaf extracts at lower concentrations. The mean diameter of the scaffolds was recorded on the SEM as 275.60 ± 60.65 nm, 193 ± 30 nm and 537 ± 138 nm for the PCL, 10% Tvio and 15% Tvio scaffolds, respectively. The FTIR spectrum revealed the presence of amide groups as well hydroxyl O–H stretching groups which were the characteristic groups for the presence of T. violacea plant extracts in the polycaprolactone. The EDS results showed the presence of potassium, chlorine and sulphur compounds which were only present in the T. violacea scaffolds in addition to the carbon, oxygen and silicon observed in the PCL scaffold. The fabricated scaffolds were then used to evaluate platelet adhesion and activation on blood plasma in the absence and presence of 100 and 1000 μg/ml T. violacea aqueous leaf extracts. The results showed that the 10% Tvio scaffold was more effective in inhibiting platelet adhesion and activation at every treatment group especially when plasma was used in the absence of T. violacea plant extracts. A similar observation to the polystyrene study was observed were addition of 1000 μg/ml of plant extract resulted in the highest number of activated platelets. The study suggests the potential of the 10% Tvio scaffold in the prevention of platelet adhesion and aggregation. The in vitro cell adhesion, proliferation and differentiation of adipose derived stem cells (ADSCs) on the fabricated T. violacea loaded PCL nanofibers was then evaluated. The LDH assay illustrated less activity on the 10% Tvio scaffold when compared to PCL and 15% Tvio scaffolds however, none of the scaffolds were considered as toxic. The alamar blue assay was used for viability after 4 and 7 days of culture. The results showed a significant increase in cell viability for all scaffolds from day 4 to day 7 with the 10% Tvio scaffold having the highest overall cell viability for both day 4 and day 7 of cell cultures. Immunofluorescence staining was then used to count the number of cells using DAPI (4′,6-diamidino-2-phenylindole) stained images and illustrated that the T. violacea incorporated scaffolds supported better cell growth compared to the PCL scaffold. Cell morphology on the T. violacea scaffolds was denser and spread out into cellular extensions when compared to the PCL scaffold after 7 days of cell culture, supporting the higher number of adhered cells from the fluorescence results. For the long term cell study after week 1 and 3, the ALP results showed a significant difference in ALP activity between week 1 and week 3 for all scaffolds. The highest ALP activity was observed for the 15% Tvio scaffolds which is a marker for initial phase of bone matrix deposition. The designed T. violacea scaffolds supported better cell growth compared to the PCL scaffold and their morphology was more spread out and covered the entire surface of the scaffolds after week 3. Lastly, the cell count and osteocalcin differentiation was more prominent on 10% Tvio scaffold indicating higher levels of the protein marker for bone formation. Thus, supporting the use of the 10% Tvio scaffold for long-term cell studies. In conclusion, the results of this study indicated that the aqueous extract of T. violacea is rich is phytochemicals and also possess a broad range of pharmaceutically important compounds which may be attributed to the high antioxidant and antimicrobial activities identified. The results from this study suggest that T. violacea aqueous extracts have antithrombogenic properties at lower concentrations. Scaffolds fabricated with the incorporation of T. violacea plant extract also confirm the potential antiplatelet activity of the fabricated 10% Tvio scaffold. The results also suggest the potential of the fabricated 10% Tvio scaffold to enhance cell adhesion, proliferation and differentiation over long-term cell studies. It can thus be recommended that T. violacea may be useful for tissue engineering applications and bone repair with prospects of preventing cardiovascular diseases associated with bone defects. This research study has provided the foundation for clinical evaluation and outlined the potential effects of T. violacea aqueous leaf extracts as a clinical drug.

The thesis is focused on the research of stability of controlled drug release systems based on a blend of plasticized starch/polycaprolactone (TPS/PCL) that served as a carrier. Antibiotic vancomycin was used as a model drug, and its release from TPS/PCL pellets into aqueous environment was followed by UV-spectroscopy and the obtained time dependences were treated by a simple kinetic model. Moreover, the simultaneous release of starch particles to the surrounding liquid phase was studied by static and dynamic light scattering as well as transmission electron microscopy (TEM) in order to obtain information on the stability of biodegradable matrix and on the structure of the products of the pellet decomposition on a nanoscale level. Key words: vancomycin, starch, drug delivery system, polycaprolactone (PCL), particle release, dynamic light scattering (DLS), static light scattering (SLS)

No description available.

Annually, about 80,000 people die in the United Kingdom due to myocardial infarction, congestive heart failure, stroke, or from other diseases related to blood vessels. The current gold standard treatment for replacing the damaged blood vessel is by autograft procedure, during which the internal mammary artery (IMA) graft or saphenous vein graft (SVG) are usually employed. However, some limitations are associated with this type of treatment, such as lack of donor site and post-surgery problems that could negatively affect the patient’s health. Therefore, this present work aims to fabricate a synthetic blood vessel that mimics the natural arteries and to be used as an alternative method for blood vessel replacement. Polymeric materials intended to be used for this purpose must possess several characteristics including: (1) Polymers must be biocompatible; (2) Biodegradable with adequate degradation rate; (3) Must maintain its structural integrity throughout intended use; (4) Must have ideal mechanical properties; and (5) Must encourage and enhance the proliferation of the cells. The feasibility of using synthetic biodegradable polymers such as poly (ε- caprolactone) (PCL) and poly (lactide-co-glycolic acid) (PLGA) for fabricating tubular vascular grafts was extensively investigated in this work. Many fundamental experiments were performed to develop porous tissue- engineered polymeric membranes for vascular graft purposes through electrospinning technique to achieve the main aim. Electrospinning was selected since the scaffolds produced by this method usually resemble structural morphology similar to the extracellular matrix (ECM). Hence, four 6mm in diameter tubular shape vascular grafts PCL only, PLGA only, coaxial (core-PCL and shell-PLGA), and bilayer (inner layer-PCL and outer layer-PLGA) was designed and fabricated successfully. The structure and properties of each scaffold membrane were observed by scanning electron microscopy (SEM), and these scaffolds were fully characterized by Fourier-transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), water contact angle measurements, mechanical tensile test, as well as cell culture studies were carried out by seeding human umbilical vein cells (HUVEC) and human vascular Fibroblast cells (HVF). Moreover, all polymeric grafts underwent degradation process, and the change in their morphological structure properties was studied over 12 weeks at room temperature. All scaffolds were also exposed to a controlled temperature of 37°C for four weeks, in phosphate-buffered saline solution (pH, 7.3). It was found that all scaffolds displayed exceptional fibre structure and excellent degradability with adequate steady weight-loss confirming the suitability of the fabricated scaffolds for tissue engineering applications. The coaxial and bilayer scaffolds degraded at a much slower (and steadier) rate than the singular PCL and PLGA tubular scaffolds. Coaxial grafts fabricated via coaxial needle showed an increase in their fibre diameter and pore size volume than other membranes, but also showed to have significant tensile strength, elongation at fracture, and Young’s modulus. To conclude, all scaffolds have demonstrated to be reliable to adhere and proliferate HUVEC, and HVF cells, but these cells were attracted to the PLGA membrane more than other fabricated membranes.